The No Surprises Act represents a rare bipartisan moment for Congress and a long-needed safeguard for patients that will reorient relationships among payers and providers.
Other featured articles
Using Behavioral Science to Inform Risk Communications
Experts from USC use behavioral sciences to help international organizations with risk messaging.Posted in
FDA’s Approval of Aducanumab Paves the Way for ‘More Momentous’ Alzheimer’s Breakthroughs
New in STAT, Dana Goldman and Darius Lakdawalla discuss how the FDA’s recent approval of the first disease modifying therapy aducanumab against Alzheimer’s disease will pave the way for bigger breakthrough.
Designing a Public Option that Would Reduce Healthcare Provider Prices
An analysis of how a public option may or may not reduce healthcare costs in the U.S.